c ebpβ-lip drug

c ebpβ-lip drug C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease - Yao - 2024 - CNS Neuroscience & Therapeutics CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

Name: c ebpβ-lip drug C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease - Yao - 2024 - CNS Neuroscience & Therapeutics CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex
Brand: vanierexcavation.com
SKU: 13860529511
Price: 21.43 USD
Availability: InStock
Rating: 4.468 (21 reviews)

CCAAT Enhancer Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding Research Transcriptional Control of COX 2 via C EBP Arteriosclerosis, Thrombosis, and Vascular Biology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect c ebp lip drug Facts Continuous Activation of C EBP Transcription A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports

SKU: 13860529511 · From vanierexcavation.com

4.5

USD21.43 USD66.43

Pay in 4 interest-free payments of $5.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

The master regulators of fatty acid oxidation, Ppara and Ppargc1a , were downregulated by 70% and 69%, accompanied by decreased transcription of genes involved in mitochondrial ( Cpt2 , Acadvl ) and peroxisomal ( Acox1 , Ehhadh ) -oxidation